A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

Photo: Carlos Barria/Reuters and Ethan Miller/Getty Images A crowd of investors gathered at Morgan Stanley’s New York office to hear X’s sales pitch, eager to get a piece of debt that Wall ...

Social media site X’s valuation has bounced back to $44 billion, according to a new report from the Financial Times. Elon Musk purchased the platform, formerly known as Twitter, for $44 billion ...

Elon Musk’s social network X has raised close to $1 billion in new equity from investors, according to people with knowledge of the matter — a deal that gives the company a valuation in line ...

Elon Musk invested $150 million to acquire more shares in X last year at a valuation approaching the price he paid for the company’s equity in 2022. Musk, who’s the majority shareholder of the ...

Their paper, "A humanized antibody against mucormycosis targets angioinvasion and augments the host immune response," was recently accepted and published in the Science Translational Medicine journal.

After its valuation plunged in recent years, X is now worth $44 billion — the same price owner Elon Musk paid for the platform, then known as Twitter, in 2022. The $44 billion valuation was ...

Months after the valuation of X (formerly Twitter) was estimated to have fallen by 80 percent, investors are now pegging the social media platform’s value at $44 billion, the same amount Elon ...